Viewing Study NCT00927758


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2026-01-16 @ 12:52 AM
Study NCT ID: NCT00927758
Status: COMPLETED
Last Update Posted: 2017-03-29
First Post: 2009-06-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair
Sponsor: Sandoz
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CP-Sandoz-2009-PilotFP
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators